These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24879966)

  • 1. A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria.
    Poddighe D; Cavagna L; Brazzelli V; Bruni P; Marseglia GL
    Autoimmun Rev; 2014 Nov; 13(11):1142-8. PubMed ID: 24879966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome in juvenile dermatomyositis: a systematic review.
    Poddighe D; Dauyey K
    Rheumatol Int; 2020 May; 40(5):695-702. PubMed ID: 31529231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature.
    Chang Y; Shan X; Ge Y
    Pediatr Rheumatol Online J; 2023 Sep; 21(1):106. PubMed ID: 37735702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of juvenile-onset clinically amyopathic dermatomyositis.
    Gerami P; Walling HW; Lewis J; Doughty L; Sontheimer RD
    Br J Dermatol; 2007 Oct; 157(4):637-44. PubMed ID: 17596148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis].
    Bustos B R; Carrasco A C; Toledo R C
    An Pediatr (Barc); 2012 Jul; 77(1):47-50. PubMed ID: 22342516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
    Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
    Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyopathic dermatomyositis: retrospective review of 37 cases.
    el-Azhary RA; Pakzad SY
    J Am Acad Dermatol; 2002 Apr; 46(4):560-5. PubMed ID: 11907509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Macrophage activation syndrome: report on three cases].
    Zietkiewicz M; Hajduk A; Wojteczek A; Smoleńska Z; Czuszyńska Z; Zdrojewski Z
    Ann Acad Med Stetin; 2012; 58(1):55-61. PubMed ID: 23547396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile Dermatomyositis With Macrophage Activation and Severe Encephalopathy.
    Jagwani H; Mondal A; Pal P
    Indian Pediatr; 2022 Sep; 59(9):725-726. PubMed ID: 36101954
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyopathic dermatomyositis.
    Olsen NJ; Park JH; King LE
    Curr Rheumatol Rep; 2001 Aug; 3(4):346-51. PubMed ID: 11470054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amyopathic dermatomyositis].
    Filo V
    Cas Lek Cesk; 2003; 142(11):648-50. PubMed ID: 14689822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis.
    Lilleby V; Haydon J; Sanner H; Krossness BK; Ringstad G; Flatø B
    Scand J Rheumatol; 2014; 43(2):171-3. PubMed ID: 24588361
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophage Activation Syndrome.
    Raj PB; Harikrishnan BL; Mampilly R; Anand R
    J Assoc Physicians India; 2017 May; 65(5):91-92. PubMed ID: 28598057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile amyopathic dermatomyositis.
    Henning JS; Witkiewicz A; Schaffer JV; Orlow SJ
    Dermatol Online J; 2005 Dec; 11(4):11. PubMed ID: 16403383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab and rituximab for anti-MDA-5 positive amyopathic dermatomyositis complicated with macrophage activation syndrome and progressive fibrosing interstitial lung disease.
    Su CF; Liao HT; Tsai CY
    Scand J Rheumatol; 2022 Mar; 51(2):166-168. PubMed ID: 34643171
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophage activation syndrome as a complication of dermatomyositis: A case report.
    Zhu DX; Qiao JJ; Fang H
    World J Clin Cases; 2020 Jun; 8(11):2339-2344. PubMed ID: 32548165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile amyopathic dermatomyositis.
    Schmid MH; Trüeb RM
    Br J Dermatol; 1997 Mar; 136(3):431-3. PubMed ID: 9115933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.